bradykinin, des-arg(9)- has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabra, BH; Sirois, P | 2 |
2 other study(ies) available for bradykinin, des-arg(9)- and Autoimmune Diabetes
| Article | Year |
|---|---|
Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice.
Topics: Animals; Blood Glucose; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Hyperalgesia; Immersion; Male; Mice; Pain Measurement; Physical Stimulation; Reaction Time; Receptor, Bradykinin B1 | 2003 |
Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor.
Topics: Age Factors; Animals; Blood Glucose; Bradykinin; Bradykinin B1 Receptor Antagonists; Diabetes Mellitus, Type 1; Female; Hyperalgesia; Mice; Mice, Inbred NOD; Pain Measurement; Receptor, Bradykinin B1 | 2005 |